Corporate Compliance Officer. SIUH will appoint a Chief Compliance Officer (“Compliance Officer”) who will have primary responsibility for the development, implementation, coordination and monitoring of SIUH’s compliance and ethics program. In addition, the Compliance Officer will be responsible for coordinating internal compliance audits, developing and overseeing SIUH’s compliance training programs, and serving as an advisor to SIUH and its employees on compliance questions and issues.
Corporate Compliance Officer. Dignity Health has appointed a Corporate Compliance Officer and shall maintain a Corporate Compliance Officer for the term of the CIA. The Corporate Compliance Officer shall be a member of senior management of Dignity Health, shall report directly and jointly to the Chief Executive Officer of Dignity Health and the Chair of the Audit and Compliance Committee of the Dignity Health Board of Directors, and shall not be or be subordinate to the General Counsel or Chief Financial Officer or have any responsibilities that involve acting in any capacity as legal counsel or supervising legal counsel functions for Dignity Health. The Corporate Compliance Officer shall be responsible for, without limitation:
a. developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program requirements;
b. making periodic (at least quarterly) reports regarding compliance matters directly to the Board of Directors (or a Committee of the Board) of Dignity Health, and shall be authorized to report on such matters to the Board of Directors at any time. Written documentation of the Corporate Compliance Officer’s reports to the Board of Directors shall be made available to OIG upon request; and
c. monitoring the day-to-day compliance activities engaged in by Dignity Health as well as for any reporting obligations created under this CIA. Any noncompliance job responsibilities of the Corporate Compliance Officer shall be limited and must not interfere with the Corporate Compliance Officer’s ability to perform the duties outlined in this CIA. Dignity Health shall report to OIG, in writing, any changes in the identity or position description of the Corporate Compliance Officer, or any actions or changes that would affect the Corporate Compliance Officer’s ability to perform the duties necessary to meet the obligations in this CIA, within five days after such a change.
Corporate Compliance Officer. Within 120 days after the Effective Date, Prime shall appoint a Corporate Compliance Officer and shall maintain a Corporate Compliance Officer for the term of the CIA. The Corporate Compliance Officer shall be an employee and a member of senior management of Prime, shall, at all times, report directly to both the Chairman, President and Chief Executive Officer of Prime Healthcare Services, Inc. and the Chair of the Board of Prime Healthcare Foundation, Inc., and shall not be or be subordinate to the General Counsel or Chief Financial Officer or have any responsibilities that involve acting in any capacity as legal counsel or supervising legal counsel functions for Prime. The Corporate Compliance Officer shall be responsible for, without limitation:
a. developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program requirements;
b. making periodic (at least quarterly) reports regarding compliance matters directly to the Board of Directors of Prime and shall be authorized to report on such matters to the Board of Directors at any time. Written documentation of the Compliance Officer’s reports to the Board of Directors shall be made available to OIG upon request; and
c. monitoring the day-to-day compliance activities engaged in by Prime as well as any reporting obligations created under this CIA. Any noncompliance job responsibilities of the Corporate Compliance Officer shall be limited and must not interfere with the Corporate Compliance Officer’s ability to perform the duties outlined in this CIA. Prime shall report to OIG, in writing, any changes in the identity of the Corporate Compliance Officer, or any actions or changes that would affect the Corporate
Corporate Compliance Officer. Community Health has appointed a Corporate Compliance Officer. Within 120 days of the effective date of this CCA, Community Health shall ensure that, pursuant to the Corporate Compliance Program, the Corporate Compliance Officer (i) will provide regular (at least quarterly) reports regarding compliance matters directly to the CEO and/or the Board of Directors of Community Health, and shall be authorized to report to the Board of Directors at any time; (ii) shall be responsible for developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CCA and with the requirements of the Federal health care programs; and (iii) shall be responsible for monitoring the day-to-day activities engaged in by CHS to further its compliance objectives as well as for any reporting obligations created under this CCA. In the event a new Corporate Compliance Officer is appointed during the term of this CCA, CHS shall notify OIG, in writing, within fifteen (15) days of such a change.
Corporate Compliance Officer. The Company’s Senior Vice President, Business Ethics, or such other person designated by the Company from time to time as responsible for ensuring the application of the Code of Conduct.
Corporate Compliance Officer. Amedisys represents that it has appointed a Corporate Compliance Officer. The Corporate Compliance Officer shall be responsible for developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health Amedisys, Inc. and Amedisys Specialized Medical Services, Inc. Corporate Integrity Agreement 2 care program requirements. The Corporate Compliance Officer shall be a member of senior management of Amedisys, shall make periodic (at least quarterly) reports regarding compliance matters directly to the Board of Directors of Amedisys, and shall be authorized to report on such matters to the Board of Directors at any time. The Corporate Compliance Officer shall be responsible for monitoring the day-to-day compliance activities engaged in by Amedisys as well as for any reporting obligations created under this CIA. Amedisys shall report to OIG, in writing, any changes in the identity or position description of the Corporate Compliance Officer, or any actions or changes that would affect the Corporate Compliance Officer’s ability to perform the duties necessary to meet the obligations in this CIA, within 15 days after such a change.
Corporate Compliance Officer. For the duration of this CIA, Fresenius shall continue to maintain an individual to serve as Corporate Compliance Officer, consistent with the following requirements. The Corporate Compliance Officer shall be responsible for ensuring the development and implementation of policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with the requirements of the Federal health care programs. The Corporate Compliance Officer shall be a member of senior management of Fresenius, shall make regular (at least quarterly) reports regarding compliance matters directly to the CEO and/or to the Board of Directors of Fresenius and shall be authorized to report to the Board of Directors at any time. The Corporate Compliance Officer shall be responsible for monitoring the day-to-day activities engaged in by Fresenius to further its compliance objectives, as well as any reporting obligations created under this CIA.
Corporate Compliance Officer. Child’s Play OT, PLLC will have a dedicated Corporate Compliance Officer (CCO) with the responsibility for the day-to-day operation of the compliance program. The CCO will report directly to the Public Health Director and will at least quarterly report the activities of the compliance program to said Director and the Corporate Compliance Committee. A brief synopsis will be given to the Board of Health (BOH) at least quarterly.
Corporate Compliance Officer. Within sixty (60) days of the effective date of this Agreement, PCL will employ a Corporate Compliance Officer, who shall have lead responsibility for implementing the Corporate Integrity Program. The Corporate Compliance Officer shall report directly to the Board of Directors and CEO of PCL. The Corporate Compliance Officer shall supervise any other compliance staff on compliance-related matters and shall be responsible for maintaining, updating, and monitoring PCL's compliance with this Agreement, the CIP, and all Applicable Laws. The Corporate Compliance Officer shall report regularly to the President of PCL concerning PCL's compliance with, implementation of and any material variance from the Corporate Integrity Program and this Agreement. The job description of the Corporate Compliance Officer will be submitted to OEC for its review.
Corporate Compliance Officer. Allina has represented to OIG that, pursuant to the Allina Compliance Program, it has established the position of Corporate Compliance Officer and appointed an individual to serve in that capacity. The Corporate Compliance Officer shall be responsible for developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program requirements. The Corporate Compliance Officer shall be a member of senior management of Allina, report directly to the Chief Executive Officer of Allina, shall make periodic (at least quarterly) reports regarding compliance matters directly to the Board of Directors of Allina, and shall be authorized to report on such matters to the Board of Directors at any time. The Corporate Compliance Officer shall be responsible for monitoring the day-to-day compliance activities engaged in by Allina as well as for any reporting obligations created under this CIA. Allina shall report to the OIG, in writing, any changes in the identity or position description of the Corporate Compliance Officer, or any material actions or material changes that would affect the Corporate Compliance Officer’s ability to perform the duties necessary to meet the obligations in this CIA within 30 days of such a change.
